EUVIMEDEUVIMED entdecken
Crossref

Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID ‐19 pandemic

Alice J Tan, Joyce Xia, Emilee Herringshaw, Omkar Mayur, Arshia Iqbal, Bethany Cucka iD, Bianca Biglione iD, Joseph J Locascio, Daniela Kroshinsky

Pediatric Dermatology · 2023

DOI: 10.1111/pde.15394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2023. Verfasst von Alice J Tan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: COVID-19, Acne Vulgaris, Dermatologic Agents. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isotretinoin is a systemic therapy approved for acne and has historically required lab monitoring in addition to adherence to the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) given the medication's teratogenic effects. The COVID‐19 pandemic resulted in the expansion of telemedicine, acceptance of remote pregnancy tests, and relaxation of lab monitoring practices. A retrospective review of 142 pediatric patients was conducted, and multivariate linear regression was performed to examine differences in prescribing patterns pre‐COVID and during COVID. Backward elimination identified gender and the interaction between acne severity and number of systemic treatments tried before isotretinoin as significant factors associated with increased number of visits to isotretinoin initiation, with females requiring more visits before starting isotretinoin at every acne severity level and even after accounting for systemic treatments previously tried. While the changes catalyzed by the pandemic may have improved visit‐related burdens for patients and caregivers, female patients with acne continue to be delayed in receiving isotretinoin even when adjusting for acne severity and systemic treatments trialed, underscoring persistent gender disparities in prescribing practices for isotretinoin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Acne VulgarisDermatologic AgentsPregnancyHumansFemaleChildIsotretinoinPandemicsRetrospective Studies

Stichwörter der Autor:innen

acnegenderisotretinoinpediatric dermatologytelemedicine

Substanzen

IsotretinoinDermatologic Agents

Autor:innen und Institutionen

  • Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Harvard Catalyst Biostatistics, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Bethany Cucka, Bianca Biglione

Zitieren

APA

Tan, A. J., Xia, J., Herringshaw, E., Mayur, O., Iqbal, A., Cucka, B., Biglione, B., Locascio, J. J., & Kroshinsky, D. (2023). Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID ‐19 pandemic. Pediatric Dermatology. https://doi.org/10.1111/pde.15394

Vancouver

Tan AJ, Xia J, Herringshaw E, Mayur O, Iqbal A, Cucka B, et al. Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID ‐19 pandemic. Pediatric Dermatology. 2023. doi:10.1111/pde.15394

BibTeX
@article{Tan2023,
  author = {Tan, Alice J and Xia, Joyce and Herringshaw, Emilee and Mayur, Omkar and Iqbal, Arshia and Cucka, Bethany and Biglione, Bianca and Locascio, Joseph J and Kroshinsky, Daniela},
  title = {Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID ‐19 pandemic},
  journal = {Pediatric Dermatology},
  year = {2023},
  doi = {10.1111/pde.15394}
}
Kostenlos starten →